Skip to main content

Proposed NIH Cuts Would Inhibit Medical Research

Posted in News on 3.30.2017

The current iteration of the federal budget proposed by the U.S. President would cut $1.2 billion to the National Institutes of Heath (NIH), though the budget needs to be approved in both houses of Congress before it can go into effect and thus modifications are possible.  The cuts target rese...


New Faces: Linda Cordell and Dr. XinQi Dong

Posted in Updates on 3.28.2017

We are excited to announce that Linda Cordell has joined Alosa Health as an academic detailer in Shelby County, TN. She will be detailing on the use of PrEP, or pre-exposure prophylaxis, as an HIV prevention strategy for high-risk individuals. Linda brings 15 years of experience in clinical nursing ...


Educational Outreach to Opioid Prescribers: The Case for Academic Detailing

Posted in Publications on 3.15.2017

Pain Physician 2017; 20:S147-S151 • ISSN 1533-3159 In recent years, deaths from accidental overdose due to prescription opioids exceeded deaths from motor vehicle accidents in the United States. Inappropriate prescribing of opioids by physicians may have contributed to this growing epidemic. A...


DC Program Closes Knowledge Gap on EPT

Posted in Updates on 3.6.2017

Alosa Health’s program in Washington, DC is having a measurable impact on healthcare providers’ knowledge of expedited partner therapy (EPT) to manage patients with STIs and their current partners. Among healthcare providers who received academic detailing through our program, none were ...


The Case for Academic Detailing with Nurse Practitioners

Posted in Publications on 3.1.2017

Journal of the American Association of Nurse Practitioners 2016; 28, 574-575 Academic detailing (sometimes called educational outreach) programs have historically been directed at physicians. However, nurse practitioners (NPs), like other clinical providers, must also stay current with the latest e...


Academic Detailing: “Marketing” the Best Evidence to Clinicians

Posted in Publications on 3.1.2017

JAMA 2017; 317(4) In 1983, Drs. Avorn and Soumerai published the seminal randomized trial that evaluated the effect of academic detailing on clinical practice. In a recent JAMA Viewpoint, Dr. Avorn describes the rationale that led to that trial’s publication as well as a few of the follow-up ...


Alosa CEO Wins Committee Appointment

Posted in Updates on 2.21.2017

Massachusetts Governor Charlie Baker recently appointed Alosa Health CEO Cheryl Bartlett to the newly minted Special Commission on Behavioral Health Promotion and Substance Use Prevention. The Commission’s purpose will be to investigate evidence-based practices, programs and systems to prevent...


Ulterior Motive in Question with Drug Companies’ Charity

Posted in News on 2.16.2017

The Massachusetts U.S. Attorney’s Office is currently leading a nationwide  investigation into drug companies’ charitable contributions toward organizations that provide financial assistance to patients whose health conditions require expensive drugs. These organizations typically c...


MA Program Reduces APMs

Posted in Updates on 1.2.2017

The second wave of Alosa Health’s Massachusetts program to reduce misuse of antipsychotic medications (APMs) in nursing homes came to a close with the 2016 calendar year. While it is too early to evaluate our impact on this group of nursing homes, we are pleased to announce that nursing homes ...


Approving a Problematic Muscular Dystrophy Drug: Implications for FDA Policy

Posted in Publications on 12.20.2016

JAMA. 2016;316(22)2257-2258 In September 2016, the head of the FDA’s Center for Drug Evaluation and Research approved a new drug (etiplersen) for the treatment of Duchenne muscular dystrophy, despite an advisory committee who voted 7 to 3 finding no evidence that the drug had clinical ef...